Submitted:
29 December 2023
Posted:
29 December 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Samples preparation
2.2. UV-VIS-NIR and FTIR
2.3. TEM and HAADF-STEM
2.4. AFM/MFM
2.5. XRD
2.6. TGA/DTA-MS-FTIR
2.713. C- NMR and 1H-NMR
2.8. Zeta potential
2.9. GPC
3. Results
3.1. NIR and FTIR spectroscopies
3.2. 13C-NMR and 1H-NMR
3.3. TEM images
3.4. AFM/MFM images
3.5. X-ray diffraction (XRD)
3.6. TGA/DTA-MS-FTIR
3.7. GPC
3.8. Zeta potential
4. Discussion with summary
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgment
Conflicts of Interest
References
- Eiji Osawa, Cornannulene, Kagaku, 25:854, 1970.
- Kroto, H.W. , Heath, J.R., O’Brien, S.C., Curl, R.F., Smalley, R.E., C₆₀: Buckministerfullerene, Nature, 318:162, 1985.
- W. Krätschmer, Lowell D. Lamb, K. Fostiropoulos & Donald R. Huffman, Solid C₆₀: a new form of carbon, Nature, 347:354–358, 1990.
- Koruga, Dj. Simi-Krstic, J., Trifunovic, M., Jankovic, S., Hameroff, S., Withers, J., Loutfy, R., Imaging Fullerene C₆₀ with atomic resolution using a scanning tunneling microscope, Fullerene Science and Technology, 1(1):93-100, 1993, ISSN: 1064-122X. [CrossRef]
- Harter, W.G. , and Weeks, D.E. Rotation-vibration spectra of icosahedral Molecule I: Icosahedral symmetry analysis and fine structure. J. Chem Phys 90(9): 4724-4743,1989. [CrossRef]
- Markus Arndt, Olaf Nairz, Julian Vos-Andreae, Claudia Keller, Gerbrand van der Zouw & Anton Zeilinger, Wave–particle duality of C60 molecules, Nature, 401: 680–682,1999.
- Kamaseki, T., and Kadota, K., The “vesicle in a basket”, J. Cell Biol 42:202-220, 1969. [CrossRef]
- Ericson, R.O. , Tubular pacing of spheres in biological fine structures, Science, 181:705-708,1973. [CrossRef]
- R. C. Haddon, Magnetism of the carbon allotropes, Nature, 378, 249–255, 1995. [CrossRef]
- Chiang, L. Y.; Upasani, R. B.; Swirczewski, J. W., Process of forming polysubstituted fullerenes U. S. Patent 5,177,248, 1993. and Chiang, L. Y.; Upasani, R. B.; Swirczewski, J. W. U.S. Patent 5,294,732, 1994.
- Sayes, C. M. , Fortner, J. D., Guo, W., Lyon, D. Y., Boyd, A. M., Ausman, K., Tao, Y. J., Sitharaman, B., Wilson, L. J., Hughes, J. B., et al. (2004). The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4, 1881–1887. [CrossRef]
- Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, Dramicanin M, Harhaji L, Raicevic N, Nikolic Z, Trajkovic V. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci. 2006 May;91(1):173-83. [CrossRef] [PubMed]
- Bogdanović, G., Kojić, V., Dordević, A., Canadanović-Brunet, J., Vojinović-Miloradov, M., & Baltić, V. V. (2004). Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity. Toxicology in vitro: an international journal published in association with BIBRA, 18(5), 629–637. [CrossRef]
- Jiao F, Liu Y, Qu Y, Li W, Zhou G, Ge C, Li Y, Sun B, Chen C. Studies on anti-tumor and antimetastatic activities of fullerenol in a mouse breast cancer model. Carbon. 2010: 48: 2231-2243. [CrossRef]
- Liu, Y., Jiao, F., Qiu, Y., Li, W., Qu, Y., Tian, C., Li, Y., Bai, R., Lao, F., Zhao, Y., Chai, Z., & Chen, C. (2009). Immunostimulatory properties and enhanced TNF- alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles. Nanotechnology, 20(41), 415102. [CrossRef]
- Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol. 2006;290(6):C1495-C1502. [CrossRef]
- Johnson-Lyles DN, Peifley K, Lockett S, et al. Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2010;248(3):249-258. [CrossRef]
- Saathoff JG, Inman AO, Xia XR, Riviere JE, Monteiro-Riviere NA. In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells. Toxicol In Vitro. 2011;25(8):2105-2112. [CrossRef]
- Shimizu K, Kubota R, Kobayashi N, et al. Cytotoxic Effects of Hydroxylated Fullerenes in Three Types of Liver Cells. Materials (Basel). 2013;6(7):2713-2722. Published 2013 Jul 9. [CrossRef]
- Koruga, Dj. Composition of Matter Containing Harmonized Hydroxyl Modified Fullerene Substance. U.S. Patent 8,058,483 B2, 15 November 2011.
- Koruga, Dj. Compositions Comprising Hyper Harmonised Hydroxyl Modified Fullerene Substances. International Patent WO 2021/110234 A1, 10 June 2021. [Google Scholar]
- Lidija Matija, Ivana Stanković, Milica Purić, Milica Miličić, Danijela Maksimović-Ivanić, Sanja Mijatovic, Tamara Krajnović,Vuk Gordić, Djuro Koruga, The Second Derivative of Fullerene C60 (SD-C60) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine, Micromachines 2023, 14, 2152. [CrossRef]
- Markelić M, Mojić M, Bovan D, Jelača S, Jović Z, Purić M, Koruga D, Mijatović S, Maksimović-Ivanić D. Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of HyperHarmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo. Nanomaterials (Basel). 2023 Jan 17;13(3):372. [CrossRef] [PubMed]
- Markelić M, Drača D, Krajnović T, Jović Z, Vuksanović M, Koruga Dj, Mijatović S, Maksimović-Ivanić D. Combined Action of Hyper-Harmonized Hydroxylated Fullerene Water Complex and Hyperpolarized Light Leads to Melanoma Cell Reprogramming In Vitro. Nanomaterials (Basel). 2022 Apr 13;12(8):1331. [CrossRef] [PubMed]
- Perovic M, Ciric J, Matovic V, Srbovan M, Koruga Dj, Kanazir S, Ivkovic S. The presymptomatic treatment with 3HFWC nanosubstance decreased plaque load in 5XFAD mouse model of Alzheimer’s disease. CNS Neurosci Ther. 2023. [CrossRef]
- Lazovic J, Zopf LM, Hren J, Gajdoš M, Slavkovic M, Jovic Z, Stankovic I, Matovic V, Koruga Dj. FullereneFiltered Light Spectrum and Fullerenes Modulate Emotional and Pain Processing in Mice. Symmetry. 2021; 13:2004. [CrossRef]
- Subotić A, Jevremović S, Milošević S, Trifunović-Momčilov M, Đurić M, Koruga Đ. Physiological Response, Oxidative Stress Assessment and Aquaporin Genes Expression of Cherry Tomato (Solanum lycopersicum L.) Exposed to Hyper-Harmonized Fullerene Water Complex. Plants. 2022;11:2810. [CrossRef]
- Miljkovic S, Jeftic B, Stankovic I, Stojiljkovic N, Koruga Dj. Mechanisms of skin moisturization with hyperharmonized hydroxyl modified fullerene substance. J Cosmet Dermatol. 2021;20:3018-3025. [CrossRef]
- Miljkovic S, Jeftic B, Sarac D, Matovic V, Slavkovic M, Koruga Dj. Influence of hyper-harmonized fullerene water complex on collagen quality and skin function. J Cosmet Dermatol. 2020;19:494–501. [CrossRef]
- Serda, M.; Szewczyk, G.; Krzysztyńska-Kuleta, O.; Korzuch, J.; Dulski, M.; Musioł, R.; Sarna, T. Developing [60]Fullerene Nanomaterials for Better Photodynamic Treatment of Non-Melanoma Skin Cancers. ACS Biomater. Sci Eng. 2020, 6, 5930–5940. [Google Scholar] [CrossRef] [PubMed]
- Castro, E.; Hernandez Garcia, A.; Zavala, G.; Echegoyen, L. Fullerenes in Biology and Medicine. J. Mater. Chem. B 2017, 5, 6523–6535. [Google Scholar] [CrossRef] [PubMed]
- Kamat, J.P.; Devasagayam, T.P.; Priyadarsini, K.I.; Mohan, H. Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications. Toxicology 2000, 155, 55–61. [Google Scholar] [CrossRef] [PubMed]
- Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med. 2007, 43, 711–719. [Google Scholar] [CrossRef] [PubMed]
- Franskevych, D.; Palyvoda, K.; Petukhov, D.; Prylutska, S.; Grynyuk, I.; Schuetze, C.; Drobot, L.; Matyshevska, O.; Ritter, U. Fullerene C60 Penetration into Leukemic Cells and Its Photoinduced Cytotoxic Effects. Nanoscale Res. Lett. 2017, 12, 40. [Google Scholar] [CrossRef] [PubMed]
- Bakry, R.; Vallant, R.M.; Najam-Ul-Haq, M.; Rainer, M.; Szabo, Z.; Huck, C.W.; Bonn, G.K. Medicinal applications of fullerenes. Int. J. Nanomed. 2007, 2, 639–649. [Google Scholar]
- Anilkumar, P.; Lu, F.; Cao, L.; Luo, P.G.; Liu, J.-H.; Sahu, S.; Ii, K.N.T.; Wang, Y.; Sun, Y.-P. Fullerenes for applications in biology and medicine. Curr. Med. Chem. 2011, 18, 2045–2059. [Google Scholar] [CrossRef] [PubMed]
- Andrievsky, G.V.; Bruskov, V.I.; Tykhomyrov, A.A.; Gudkov, S.V. Peculiarities of the antioxidant and radioprotective effects of hydrated C-60 fullerene nanostuctures in vitro and in vivo. Free Radical. Biol. Med. 2009, 47, 786–793. [Google Scholar] [CrossRef]
- Sharma, S.K.; Chiang, L.Y.; Hamblin, M.R. Photodynamic therapy with fullerenes in vivo: Reality or a dream? Nanomedicine 2011, 6, 1813–1825. [Google Scholar] [CrossRef] [PubMed]
- K.N. Semenov, N.A. Charykov, V.N. Postnov, V.V. Sharoyko, I.V. Vorotyntsev, M.M. Galagudza, I.V. Murin, Fullerenols: Physicochemical properties and applications, Progress in Solid State Chemistry, Vol. 44, 59-74, 2016. [CrossRef]
- Konstantin, N. Semenov, Elena V. Andrusenkoa, Nikolai A. Charykovb, Elena V. Litasovac, Gayane G. Panovad, Anastasia V. Penkovaa, Igor V. Murina, Levon B. Piotrovskiy, Carboxylated fullerenes: Physico-chemical properties and potential applications, Progress in Solid State Chemistry, Vol. 47-48,19-36, 2017. [CrossRef]
- Vileno, B.; Marcoux, P.R.; Lekka, M.; Sienkiewicz, A.; Feher, T.; Forro, L. Spectroscopic and photophysical properties of a highly derivatized C-60 fullerol. Adv. Funct. Mater. 2006, 16, 120–128. [Google Scholar] [CrossRef]
- Guldi, D.M.; Prato, M. Excited-state properties of C(60) fullerene derivatives. Accounts Chem. Res. 2000, 33, 695–703. [Google Scholar] [CrossRef]
- Dresselhaus, M.S. , Dresselhaus, M.S.,Eklund, P.C., Science of Fullerenes and Carbon Nanotubes, Academic Press, San Diego,1996.
- Kettle, S.F.A., Symmetry and structure, John Willey and Sons, Chichester, 1995.


















![]() |
| Test item | Temperature (°C) |
pH | Zeta potential (mV) |
Electrophoretic mobility (μm/s)/(Vcm) |
Conductivity (μS/cm) |
|---|---|---|---|---|---|
| Fullerenol (FD-C60) | 25 | 9.35 | -25.85 ±1.71 | -2.01±0.13 | 0.18 |
|
3HFWC (SD-C60) |
25 | 7.11 | -43.29±1.23 | -3.37±0.10 | 0.17 |
| Difference | 0 | 2.24 | -17.44 | -1.36 | 0.01 |
| Peak | C60 | Fullerenol | C60/Fulerenol (shift/ difference) | 3HFWC | C60/Fulerenol (shift/ difference) |
|
|---|---|---|---|---|---|---|
|
1. |
Wavelength (nm) | 7.003 | 6.370 | 633 | 7.340 | 337 |
| Intensity (a.u.) | 0.192 | 0.190 | 0.002 | 0.027 | 0.165 | |
|
2. |
Wavelength (nm) | 8.453 | 7.555 | 898 | 8.220 | 665 |
| Intensity (a.u.) | 0.210 | 0.178 | 0.032 | 0.028 | 0.150 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
